Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.463NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.357NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.318NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.557NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.119NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.160NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.526NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.201NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.221NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.410NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.411NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.109NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.361NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.417NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.442NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.106NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
D.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.593NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.290NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.341NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.69 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.407NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.423NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.281NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.230NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.535NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17727.2South Korea
B.1.564.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.345NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used